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Introduction: Limited population-based epidemiologic information about sepsis’ demography, including its mortality
and temporal changes is available from developing countries. We investigated the epidemiology of sepsis deaths in
Brazil using secondary data from the Brazilian Mortality Information System.
Methods: Retrospective descriptive analysis of Brazilian multiple-cause-of-death data between 2002 and 2010, with
sepsis-associated International Classification of Diseases, 10th Revision (ICD-10) code indicated as the cause of death.
Population-based sepsis associated mortality rates and trends were estimated. Annual population-based mortality rates
were calculated using age-stratified population estimates from the 2010 census provided by the Brazilian Institute of
Geography and Statistics as denominators.
Results: The total number of annual deaths recorded in Brazil increased over the decade, from 982,294 deaths
reported in 2002 to 1,133,761 deaths reported in 2010. The number of sepsis associated deaths also increased
both in absolute numbers and proportions from 95,972 (9.77% of total deaths) in 2002 to 186,712 deaths (16.46%) in
2010. The age-adjusted rate of sepsis-associated mortality increased from 69.5 deaths per 100,000 to 97.8 deaths per
100,000 population from 2002 to 2010 (P <0.001). Sepsis-associated mortality was higher in individuals older than
60 years of age as compared to subjects aged 0 to 20 years (adjusted rate ratio 15.7 (95% confidence interval (CI)
15.6 to 15.8)) and in male subjects (1.15 (95% CI 1.15 to 1.16)).
Conclusions: Between 2002 and 2010 the contribution of sepsis to all cause mortality as reported in
multiple-cause-of-death forms increased significantly in Brazil. Age-adjusted mortality rates by sepsis also increased in
the last decade. Our results confirm the importance of sepsis as a significant healthcare issue in Brazil.Introduction
Sepsis represents a substantial health care and economic
burden worldwide. Reported case fatality rates range from
29 to 60% [1-3]. Treatment costs are estimated at $16.7
to $24.3 billion annually in the US [3,4]. Sepsis incidence
has increased in the past decades [1,5,6]. In the US, nearly
3% of patients admitted to hospital have sepsis, and half of
these patients are treated in the ICU, accounting for ap-
proximately 10% of all ICU admissions [4]. Similar rates
have been described in other developed countries [7-9].* Correspondence: lucianoazevedo@uol.com.br
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unless otherwise stated.In contrast, limited information on sepsis epidemi-
ology, in particular sepsis-related mortality and trends,
are available in developing countries. A few recent studies
on the topic have been conducted in Brazil [10], China
[11], Taiwan [12], Slovak Republic [13], Thailand [14] and
Colombia [15]. Nevertheless, reported data are usually not
representative, being limited to a single hospital or repre-
senting data (for example, from ICU-admitted patients
only), which cannot be extrapolated to the population. Up
to now, limited population-based estimates of sepsis on a
national level for these countries have been conducted and
the burden of the disease in those parts of the world re-
mains largely uncharacterized [16]. Likewise, the epidemi-
ology of sepsis-related mortality in Brazil has not been
reported from a countrywide perspective.
In this study, we investigated the epidemiology of sepsis
deaths in Brazil from 2002 to 2010 using data from theral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Taniguchi et al. Critical Care 2014, 18:608 Page 2 of 7
http://ccforum.com/content/18/6/608Brazilian National Mortality Information System (Sistema
de Informações de Mortalidade (SIM)). Our aim was to
evaluate trends and provide population-based estimates of
sepsis-associated mortality during this period.
Material and methods
Study design
We conducted a descriptive study of a retrospective co-
hort of multiple-cause-of-death data registered in the
National Mortality Registry.
Sources of data
Data routinely reported to the SIM for the years 2002 to
2010, extracted on 28 March 2012, were considered for
the analysis. SIM is an electronic, case-based national
mortality registry, which derives its information from
death certificates. Sepsis-related deaths from 2002 to 2010
were identified based on International Classification of
Disease, 10th Revision (ICD-10) codes reported for each
record of the registry. Information about cause of death
available on death certificates includes: part 1: the under-
lying cause-of-death, the immediate cause-of-death, and
the sequence of contributing causes from the underlying
to the immediate cause; and part 2: any conditions not dir-
ectly leading to death but contributing to it. Codes re-
corded as underlying and/or contributing cause-of-death
were considered. In Brazil, death certificate information is
collected by trained mortality coders (after appropriate
training according to the World Health Organization
standards). They work in statistical regional offices of the
Ministry of Health and use mortality-coding software
specifically designed for this purpose. This practice has
remained constant since 1996 (when ICD-10 was intro-
duced in Brazil). Population estimates were obtained from
the Brazilian Institute of Geography and Statistics (Instituto
Brasileiro de Geografia e Estatística (IBGE)) [17].
Case definitions
Sepsis-associated deaths were defined as those in which
the following ICD-10 codes were indicated as any of the
causes of death in part 1 of the death certificate: A39,
A40 and A41 (including their associated subcodes), A02.1,
A22.7, A26.7, A32.7, A 39.2, A39.4, A42.7, B00.7, B37.7
(Additional file 1: Table S1). In addition, in order to iden-
tify cases of deaths potentially related to severe sepsis, we
selected cases with ICD-10 codes related to any bacterial,
protozoan, viral or fungal infections with one or more
codes related to organ dysfunction in part 1 of the
death certificate (as such, cases of deaths potentially
related to severe sepsis include cases of sepsis-associated
deaths). Presence of organ dysfunction (cardiovascular,
hematologic, hepatic, metabolic, neurologic, respiratory
and renal) considered codes listed as the underlying or any
other cause of death from part 1 of the death certificate(Additional file 1: Table S2). Presence of underlying comor-
bidities considered codes listed on parts 1 and 2 of the
death certificate (Additional file 1: Table S3). These defini-
tions are slightly modified versions of classifications used
by other authors in similar studies [1,4-6,16,18].
When two or more codes were reported in a single
cause-of-death variable, separated by a space or a symbol,
both of them contributed to the analysis. For this reason,
when adding the number of the total reported number of
organ failures or comorbidities, more than four may have
been reported, despite four being the number of lines avail-
able in the death certificate to report immediate and con-
tributing causes-of-death.
Exclusion criteria
Neonatal and puerperal sepsis-associated deaths (ICD-10
codes P36 and O85, respectively) were excluded from this
analysis, as their causes, epidemiological features, preven-
tion and control strategies are different to those related to
general sepsis.
Data analysis
From all deaths recorded in the registry during the
study period, all cases of sepsis-associated deaths and
deaths potentially related to severe sepsis were iden-
tified. The proportion of sepsis deaths for the study
period and for every 2-year period was calculated consid-
ering the number of sepsis-associated deaths in the nu-
merator and the total number of deaths in Brazil in the
denominator.
Annual population-based mortality rates were calcu-
lated for the study period, considering the number of
sepsis-associated deaths and deaths potentially related to
severe sepsis as numerators and the total Brazilian popu-
lation by year in the denominator. We used the direct
standardization method to standardize mortality rates in
order to compare them over time. Crude and standardized
annual mortality rates were calculated for the period of
2002 to 2010, considering the Brazilian 2010 Census age-
stratified population as the standard. We describe the pro-
portion of sepsis-associated deaths by gender, age group,
place of occurrence, presence of comorbidities and pres-
ence of organ dysfunction. We also tested the association
between the above variables and sepsis-associated deaths
for the year of 2010.
We used Poisson regression with a logarithmic link
function and an offset equal to the log of the population
to explore the effects of age group and gender on sepsis-
associated deaths mortality rates. Multivariate analysis
was used to control for confounders and test for interac-
tions. P-values <0.05 were considered statistically signifi-
cant. However, as the analyses were done with national
data and therefore include a large number of events, even
small differences can become significant. Thus, when a
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the stratified rates only when the interaction term repre-
sented 10% or more of the combined effect of its variables.
Analyses were done using Stata 12 (Stata Corporation,
College Station, Texas, USA).
Ethical approval for this study was obtained from the
Ethical Committee of Hospital Sírio-Libanês, Sao Paulo,
Brazil (CAAE: 01063212.1.0000.5461 - 3 January 2012).
Results
We identified a total of 9,407,764 deaths in Brazil from
2002 to 2010. The annual number of deaths recorded
in SIM increased over time. While in 2002, 982,294
deaths were reported, in 2010 this number increased
to 1,133,761 deaths. Similarly, there is an increase in
the number of sepsis-associated deaths and deaths
potentially related to severe sepsis during the entire
period (Figure 1). The proportion of sepsis-associated
deaths relative to the total of deaths also increased
significantly from 9.77% in 2002 to 16.46% in 2010
(Table 1).
ICD-10 code A41.9 for Septicemia unspecified was in-
dicated in 98.75% of all sepsis-associated deaths. Chapter
XVIII codes R65.1 (Systemic inflammatory response syn-
drome (SIRS)) and R65.2 (Severe sepsis) were not re-
ported in the SIM database during the study period.
Reported characteristics of sepsis-associated deaths by
period are shown in Table 2. The vast majority of sepsis
deaths occurred in the hospital. More than two thirds of
the patients who died with sepsis had one comorbidity
or no comorbidities. Of these, cancer, diabetes mellitus and
arterial hypertension were the most frequent. Roughly 20%Figure 1 Rates of sepsis-associated deaths (SAD) and deaths potentiaof the sepsis-associated deaths were in patients with had at
least one organ failure, the respiratory system being the
most frequent dysfunction.
Crude sepsis-associated mortality rates increased 77.5%
during the study period, from 55.1 in 2002 to 97.8/100,000
population in 2010. After age standardization, mortality
rates increased 40.7% from 69.5 in 2002 to 97.8 deaths
per 100,000 population in 2010. This is equivalent to a
linear increase of 3.5 deaths/100,000 population per year
(P <0.001) (Figure 2).
When analyzing crude sepsis-associated deaths rates
by age group, two peaks were demonstrated, the first
corresponding to deaths in early childhood, the second
in the elderly (Figure 3).
Table 3 shows the crude and adjusted rate ratios of
sepsis-associated deaths for age groups and gender, con-
sidering all study years. Sepsis-associated mortality in-
creased significantly by age group, being particularly
higher in the elderly (60 years and older). Also, sepsis-
associated mortality is significantly higher (15%) in men
when compared to women.
Discussion
To our knowledge, this is the first longitudinal, population-
based study of deaths associated with sepsis in Brazil.
We found that 12.9% of all Brazilian deaths from 2002
to 2010 were related to sepsis, and that both crude and
age-standardized sepsis-associated mortality rates were
increasing significantly in this period of time. Two peaks
of sepsis-related mortality corresponding to early child-
hood and in the elderly were observed. Moreover, sepsis-
associated mortality rates were higher for men.lly related to severe sepsis (DPRSS). Brazil, 2002 to 2010.
Table 1 Number of total deaths, sepsis-associated deaths,
deaths potentially related to severe sepsis, and population
during the study period
Year Total deaths SAD DPRSS Population % SAD/total
deaths
2002 982,294 95,972 152,482 174,632,932 9.77
2003 1,002,340 102,065 159,181 176,876,251 10.18
2004 1,024,073 111,202 171,751 179,108,134 10.85
2005 1,006,828 119,184 176,643 184,184,074 11.83
2006 1,031,150 131,951 192,475 186,770,613 12.79
2007 1,047,528 141,709 203,138 189,335,191 13.52
2008 1,077,007 153,748 214,964 189,612,814 14.27
2009 1,102,783 170,668 237,032 191,481,045 15.47
2010 1,133,761 186,712 252,263 190,755,799 16.46
Trend
P-values
NA 0.004 0.004 NA 0.003
Brazil, 2002 to 2010. SAD, sepsis-associated deaths; DPRSS, deaths potentially
related to severe sepsis. NA, not applicable.
Table 2 Reported characteristics of sepsis-associated deaths
Characteristics Values
Age, years, mean ± SD 64.4 ± 23.4
Male sex, % 51.1







Chronic obstructive pulmonary disease 5.7
Congestive heart disease 5.2























Brazil, 2002 to 2010.
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and developing countries [10-15]. Our data demonstrate
an increase in sepsis-associated deaths (absolute increase
of 6.7%) in eight years. Other authors have demonstrated
a similar increase in the number of sepsis-associated
deaths using hospitalization databases in the US [1,5,6].
While Melamed et al. demonstrated a crude sepsis mor-
tality rate of 50.49/100,000 population in 1999 to 2005
[5], Lagu et al. reported rates of 87/100,000 in 2007 [3],
also using secondary data from hospitalization databases.
This represents an increase of 72% in mortality rates,
which may be related to increasing trends in sepsis mor-
tality rates in the US. Similarly, we observed an increase
of 77.5% in an equivalent period of time in Brazil.
Several authors demonstrated that sepsis-associated
mortality rates, the incidence of sepsis and the hospitali-
zations due to sepsis are increasing [1-3,5,6]. However,
age-adjusted case-fatality rates have been decreasing
over time in several studies conducted in developed
countries, possibly reflecting improvement in access to
healthcare and better management of sepsis admitted to
hospitals [1,3,5]. Recently, studies reported that better
compliance with guidelines for sepsis treatment was as-
sociated with improved outcomes [19-21]. This might
explain why case-fatality is decreasing. Another issue ac-
knowledged by Lagu et al. is the difference in coding of
sepsis and organ dysfunction by hospitals when filling
hospitalization admission and discharge reports, due to
financial issues [3]. As some of these databases are used for
reimbursement purposes, this might be linked to financial
incentives for coding organ dysfunctions, leading to an in-
creased observed incidence of mild dysfunctions [3]. Our
analysis was conducted using data obtained from thenational mortality registry, which are generated from death
certificates and not used for reimbursement purposes. This
data source has fewer fields to input information (in com-
parison to hospital databases), with no direct relation
to clinical data. This might explain why most sepsis-
associated deaths had no organ failure reported, which is
unlikely, as probably cases of sepsis will have some organ
failure at some point over the course of the disease leading
to death. This is clearly a restriction of administrative data-
bases and, as such, a limitation of the present study.
Figure 2 Crude and age-standardized (using the 2010 Census
population as the standard) sepsis-associated mortality rates
per 100,000 population. Brazil, 2002 to 2010.
Table 3 Sepsis-associated mortality rates and rate ratios,









0 to 19 years (ref) 19.3 1.0 1.0
20 to 60 years 34.2 1.77 (1.76, 1.79) 1.78 (1.76, 1.79)
60+ years 297.3 15.6 (15.5, 15.7) 15.7 (15.6, 15.8)
Gender
Female (ref) 67.8 1.0 1.0
Male 78.2 1.08 (1.07, 1.08) 1.15 (1.15, 1.16)
Brazil, 2002 to 2010. ref, reference.
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patients provided relevant information on some epide-
miologic aspects of sepsis. The BASES study, which eval-
uated five Brazilian ICUs in 2001 to 2002, observed 30.5
cases of sepsis/100 ICU admissions. The overall mortal-
ity rate for sepsis was 21.8%, and it was 52.2% for pa-
tients with septic shock [10]. In another study, 13.4% of
ICU admissions were due to severe sepsis, with mortality
rates as high as 59.4% [22]. Not only are sepsis ICU ad-
mission rates high, but so too are the reported associ-
ated costs. Sogayar et al. showed a median ICU cost of
U$9,632 per patient in a Brazilian study conducted in 21
mixed ICUs in private and public hospitals [23]. To date,
trends in the nationwide burden of sepsis over time have
not been reported in Brazil. All Brazilian sepsis-related
studies have only been done in ICU patients, which
might underestimate the overall epidemiologic burden of
sepsis in the country. Rezende et al. has demonstratedFigure 3 Crude sepsis-associated mortality rates by age-group.
Brazil, 2002 to 2010.that only one third of patients with severe sepsis admitted
to the emergency department of a public tertiary urban
hospital in Brazil were referred to an ICU [24]. This sug-
gests that the true sepsis prevalence in hospitals may be
much higher than the one observed in ICU only. Resource
constraints such as scarcity of ICU beds and high ICU-
related costs could be some of the factors that might ex-
plain why septic patients are not always admitted to an
ICU. The consequence of this fact may be the higher mor-
tality due to sepsis in Brazil, as demonstrated in previous
studies [25]. The results obtained in this study, due to its
population characteristic, are significant to unequivocally
characterize the importance of the disease nationwide.
A recent study evaluated sepsis-associated mortality in
England using data from a national mortality database
comprising data derived from death certificates [26].
The authors observed that 4.7% of deaths between 2001
and 2010 were associated with sepsis (compared to 12.9%
in our study in an equivalent period of time). Similarly to
our study, mortality rates were higher in men and in-
creased by age group, with the most significant increase
in the elderly. There are relevant advantages of using na-
tionwide routinely collected data such as in our study
and the English study for assessing the epidemiology of
sepsis. First, long time-series data are readily available for
analysis. Second, these data are usually representative of
the whole population, and therefore provide a better pic-
ture of the nationwide situation. The main disadvantage
of using such data sources is that nationwide population-
based databases, hospitalization and mortality, are mainly
collected for administrative purposes. As such, they tend to
have some degree of incompleteness and are more subject
to systematic and random errors when compared with data
from observational studies. Our data on the low prevalence
of organ dysfunction in sepsis-associated deaths from our
database is an example of these possible limitations.
In this study, we found an increase in sepsis mortality
with age after the first years of life, especially in the elderly
subgroup. Others authors have previously demonstrated
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lated to age, reinforcing the generalizability of our find-
ings [4,5,12]. Since there is now an escalation in the
proportion of older patients in our country, and the mor-
tality is higher in this subgroup, a further increment in
sepsis-associated mortality rates might be expected in the
next few years. It should be acknowledged that this
change in life expectation might also increase the popula-
tion at higher risk of death after a septic episode, which
could be one of the reasons for the increment in sepsis-
associated deaths observed in our study.
Besides the limitations described previously, another
possible explanation for the increase in sepsis deaths over
time observed in our study is an improvement in notifica-
tions of sepsis in death certificates and in data acquisition.
Rhee et al. recently discussed this possibility, emphasizing
the lack of reliable tools to measure sepsis incidence. More
important, they suggested that hospitalization rates of sep-
sis in America are increasing, but infection rates are stable
or decreasing. This may be due to differences in coding
practice associated with changes in reimbursement values
instead of a true increase in sepsis rates [27]. However, in
Brazil, there are no major modifications in reimbursement
values for coding associated with organ dysfunction. In
addition, we searched for pneumonia-associated deaths in
the same period in our country and we observed an in-
crease at a similar rate to sepsis-associated deaths (data
not shown). This is in clear contrast to Rhee’s data, and re-
inforces the burden of infection-associated deaths in
Brazil. In fact, it is possible that our results still underesti-
mate the real burden of sepsis, as death certificate analysis
might underestimate infections as a cause of death [28].
Finally, another limitation of our study is the data abstrac-
tion using ICD-10 coding from death certificates. Other
approaches (such as Angus Implementation) are available,
but inaccuracies are still present [29,30]. On the other
hand, previous studies using death certificates have been
published with results similar to ours [6,26], strengthening
our findings.
Conclusions
In conclusion, sepsis-associated mortality in Brazil is
relevant due to its increasing number of deaths in recent
years, a trend not related solely to the aging population.
Our data confirm the importance of sepsis as a signifi-
cant healthcare issue in Brazil.
Key messages
 This is the first longitudinal, population-based study
of sepsis-associated deaths in Brazil
 From 2002 to 2010, 12.9% of all Brazilian deaths were
related to sepsis and both crude and age-standardized
sepsis associated mortality rates are increasing In Brazil, sepsis-related deaths are higher in early
childhood and the elderly, and males have higher
rates of death than females.
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